Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 12/20 | 1.00 |
| ▸ | PDCD1 | Q15116 | 3/20 | 1.00 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558512 | 1.00 | CD274 (1.00) | CD274PDCD1EPHX1DPP4PTGS1 | |
| SCHEMBL16245269 | 0.87 | PDCD1 (0.76) | CD274PDCD1EPHX1PTGS1KMT2A | |
| SCHEMBL607544 | 0.83 | CD274 (0.71) | CD274PDCD1EPHX1DPP4PTGS1 | |
| SCHEMBL30828918 | 0.82 | PDCD1 (0.70) | CD274PDCD1EPHX1PTGS1 | |
| SCHEMBL22401073 | 0.82 | PDCD1 (0.70) | CD274PDCD1EPHX1PTGS1 | |
| SCHEMBL18367730 | 0.82 | CD274 (0.70) | CD274PDCD1EPHX1KMT2AHSD17B10 | |
| SCHEMBL30091380 | 0.82 | PDCD1 (0.69) | CD274PDCD1EPHX1ALDH1A1 | |
| SCHEMBL11074941 | 0.82 | PDCD1 (0.69) | CD274PDCD1EPHX1ALDH1A1 | |
| SCHEMBL7107915 | 0.82 | CD274 (0.69) | CD274PDCD1EPHX1DPP4PTGS1 | |
| SCHEMBL21153739 | 0.82 | CD274 (0.69) | CD274PDCD1EPHX1DPP4PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569567-A | Preparation method of bifenthrin | 山东智荟检测科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-118702774-A | Preparation method and application of polypeptide coupling compound of targeted GPC-3 protein | 上海大学 | 2024-09-27 | — | — | CN | claimed |
| CN-115181120-B | Preparation method of 2-methyl-3-phenylstyryl pinacol borate | 山东百启生物医药有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115043784-B | Biphenyl-1, 2, 3-triazole conjugate and preparation method and application thereof | 浙江工业大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117683021-A | PD-1/PD-L1 pathway targeting compound and nuclide marker, preparation and application thereof | 厦门大学 | 2024-03-12 | — | — | CN | claimed |
| CN-116947779-A | Cyclic micromolecule compound and preparation method and application thereof | 南方医科大学 | 2023-10-27 | — | — | CN | claimed |
| CN-115181120-A | Preparation method of 2-methyl-3-phenyl styryl pinacol borate | 山东百启生物医药有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-115043784-A | Biphenyl-1, 2, 3-triazole conjugate and preparation method and application thereof | 浙江工业大学 | 2022-09-13 | — | — | CN | claimed |
| CN-114573563-A | Bifunctional molecular compound for inducing PD-L1 protein degradation and preparation and application thereof | 沈阳药科大学 | 2022-06-03 | — | — | CN | claimed |
| CN-108218696-B | Production process of bifenthrin | 江苏优嘉植物保护有限公司 | 2021-03-26 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6875885-B2 | Process for the preparation of enantiomerically pure pyrethroid insecticides | SYNGENTA LIMITED (GB) | 2005-04-05 | — | — | US | claimed |
| US-20030199709-A1 | Process for the preparation of enantiomerically pure pyrethroid insecticides | SYNGENTA LIMITED (GB) | 2003-10-23 | — | — | US | claimed |
| CN-1443153-A | Process for preparation of enantiomerically pure pyrethroid insecticides | SYNGENTA LTD (GB) | 2003-09-17 | — | — | CN | claimed |
| WO-2003053905-A1 | A PROCESS FOR THE PRODUCTION OF 1R PYRETHROID ESTERS | SYNGENTA LIMITED (GB) | 2003-07-03 | — | — | WO | claimed |
| EP-1303474-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE PYRETHROID INSECTICIDES | Syngenta Limited (GB) | 2003-04-23 | — | — | EP | claimed |
| WO-2002006202-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE PYRETHROID INSECTICIDES | SYNGENTA LIMITED (GB) | 2002-01-24 | — | — | WO | claimed |
| EP-0063374-B1 | SUBSTITUTED BIPHENYL COMPOUNDS | FMC Corporation (US) | 1984-02-22 | — | — | EP | claimed |
| EP-0063374-A1 | Substituted biphenyl compounds | FMC Corporation (US) | 1982-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199709-A1 | Process for the preparation of enantiomerically pure pyrethroid insecticides | CYP4B1, CYP4A11, DDT | CD274 4787/4885PDCD1 4337/4885EPHX1 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.